Biological treatments for severe asthma

医学 哮喘 奥马佐单抗 疾病 重症监护医学 免疫学 内科学 免疫球蛋白E 抗体
作者
Sara M. Assaf,Nicola A. Hanania
出处
期刊:Current Opinion in Allergy and Clinical Immunology [Lippincott Williams & Wilkins]
卷期号:19 (4): 379-386 被引量:29
标识
DOI:10.1097/aci.0000000000000549
摘要

Asthma is a heterogenous disease associated with different phenotypes and endotypes. The unmet needs with severe asthma have led to the emergence of potential therapeutic targets beyond the existing therapies. Recently, several biologics were examined and some have now been approved to target T2 airway inflammation in patients with severe disease. We provide an overview of recently approved biologic, those which are emerging and highlight unmet needs in this area.Multiple biologics targeting T2 high asthma are now available for clinical use in the appropriate groups of severe asthma. These target overlapping phenotypes, which include allergic and eosinophilic asthma. Available biologics were shown to improve outcomes that include the reduction of exacerbations and improvement of lung function. Some have also demonstrated improvement in patient-reported outcomes. Some of these biologics have also demonstrated beneficial effects on associated asthma comorbidities. Biomarkers help predict response to certain biologics, although only few currently exist. Emerging biologics blocking other pathways of airway inflammation are under development. Several small molecule antagonists and inhibitors are also in development. Biologics and therapies targeting T2 low or non-T2 asthma are needed.Recently approved biologic therapies improve asthma outcomes in subset of patients. Future research to uncover better predictors of response can improve the precise approach to therapy of patients with severe disease.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI5应助实验顺利采纳,获得30
刚刚
瞿寒发布了新的文献求助30
刚刚
辉HUI发布了新的文献求助10
2秒前
老实莫言完成签到,获得积分10
2秒前
科研通AI5应助似鱼采纳,获得10
3秒前
阳阳完成签到,获得积分10
4秒前
4秒前
沉默靳完成签到,获得积分10
4秒前
吼吼哈哈发布了新的文献求助10
5秒前
李爱国应助烂漫夜梅采纳,获得10
5秒前
英姑应助Hollen采纳,获得50
6秒前
随便起个名完成签到,获得积分10
6秒前
ff发布了新的文献求助10
7秒前
7秒前
顾海东完成签到,获得积分10
7秒前
小次之山发布了新的文献求助10
7秒前
艺凯完成签到,获得积分10
9秒前
慕青应助kunkun采纳,获得10
10秒前
11秒前
健忘傲柏完成签到,获得积分10
12秒前
13秒前
14秒前
15秒前
16秒前
领导范儿应助猫与咖啡采纳,获得10
16秒前
竹筏过海应助bingchem采纳,获得30
16秒前
17秒前
yangya发布了新的文献求助100
18秒前
19秒前
忘久完成签到,获得积分10
19秒前
20秒前
鱿鱼炒黄瓜完成签到,获得积分10
21秒前
CipherSage应助旧辞采纳,获得10
22秒前
zp发布了新的文献求助10
22秒前
似鱼发布了新的文献求助10
22秒前
22秒前
科研通AI5应助研究牲采纳,获得10
23秒前
wanci应助hob采纳,获得10
25秒前
25秒前
8R60d8应助随风采纳,获得10
26秒前
高分求助中
All the Birds of the World 4000
Production Logging: Theoretical and Interpretive Elements 3000
Animal Physiology 2000
Les Mantodea de Guyane Insecta, Polyneoptera 2000
Am Rande der Geschichte : mein Leben in China / Ruth Weiss 1500
CENTRAL BOOKS: A BRIEF HISTORY 1939 TO 1999 by Dave Cope 1000
Machine Learning Methods in Geoscience 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3740949
求助须知:如何正确求助?哪些是违规求助? 3283763
关于积分的说明 10036623
捐赠科研通 3000513
什么是DOI,文献DOI怎么找? 1646539
邀请新用户注册赠送积分活动 783771
科研通“疑难数据库(出版商)”最低求助积分说明 750427